Magazine Patients Safety 
NORML
FEBRUARY 26, 2019
In addition to fighting to defend the privacy of medical marijuana patients, advocates are also educating lawmakers about the discriminatory nature of drug testing and the benefits of impairment detection to address workplace safety. “A drug test for marijuana does not detect active THC.
Alchimia
MARCH 16, 2016
Once the disease starts affecting the person, life expectancy greatly depends on patients (from 3 to 20 years), with an average of 8,5 years. Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Cannabis patient. Source: Spanish Society of Neurology ).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
FEBRUARY 22, 2022
Thomas Arkell, explains that “individuals are better to wait a minimum length of time, between three and 10 hours, depending on the dose and route of administration, following cannabis use before performing safety-sensitive tasks. Yet impairment may be subjective to each consumer. .
Cannabis Law Report
MARCH 1, 2019
The group aims to meet the needs of the legal cannabis industry by addressing quality and safety issues through the development of classifications, specifications, test methods, practices, and guides for cultivation, manufacturing, quality assurance, laboratory considerations, packaging and security. D37 Feature Magazine. D37 Briefing.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. The states’ situation varies substantially.
Freedom Leaf
OCTOBER 15, 2018
On July 23, the World Health Organization’s Expert Committee on Drug Dependence stated that “no public health problems have been associated with CBD use” and that “CBD has been found to be generally well tolerated with a good safety profile.” If you enjoyed this Freedom Leaf article, subscribe to the magazine today!
Cannabis Law Report
JUNE 25, 2021
Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe. In 2010, The Times Eureka science magazine included him in the 100 most important figures in British Science, and the only psychiatrist.
Expert insights. Personalized for you.
209 
Let's personalize your content